Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype

The characteristics of brain metastases (BM) that develop after breast-conserving therapy (BCT) for early-stage breast cancer (BC) remain incompletely defined. We examined 1,434 consecutive patients with stage I/II invasive BC who received BCT from 1997 to 2006, 91 % of whom received adjuvant system...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 2012-11, Vol.136 (1), p.153-160
Hauptverfasser:	Arvold, Nils D., Oh, Kevin S., Niemierko, Andrzej, Taghian, Alphonse G., Lin, Nancy U., Abi-Raad, Rita F., Sreedhara, Meera, Harris, Jay R., Alexander, Brian M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biological and medical sciences Brain Brain Neoplasms - epidemiology Brain Neoplasms - secondary Brain Neoplasms - therapy Breast cancer Breast Neoplasms - epidemiology Breast Neoplasms - pathology Breast Neoplasms - therapy Cancer research Cancer therapies Clinical Trial Female Follow-Up Studies Gynecology. Andrology. Obstetrics Humans Incidence Kaplan-Meier Estimate Lumpectomy Mammary gland diseases Medical sciences Medicine Medicine & Public Health Metastasis Middle Aged Neoplasm Staging Neurology Oncology Radiosurgery Radiotherapy, Adjuvant Receptor, ErbB-2 - metabolism Receptors, Estrogen - metabolism Receptors, Progesterone - metabolism Risk factors Tumors Tumors of the nervous system. Phacomatoses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!